User profiles for M. A. O'Rourke

Maureen O'Rourke

Professor of Law, Boston University
Verified email at bu.edu
Cited by 2486

[HTML][HTML] Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

…, S Tejwani, AF Schott, MA O'Rourke… - Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Increased circulating tumor cells (CTCs; five or more CTCs per 7.5 mL of whole
blood) are associated with poor prognosis in metastatic breast cancer (MBC). A randomized …

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089

…, PJ Catalano, JS Macdonald, MA O'Rourke… - Journal of Clinical …, 2005 - ascopubs.org
Purpose In 1990, fluorouracil (FU) plus levamisole for 1 year became standard adjuvant
treatment for patients with high-risk stages II and III colon cancer. Intergroup (INT) 0089 …

Toward a doctrine of fair use in patent law

MA O'Rourke - Colum. L. Rev., 2000 - HeinOnline
… In this Article, Professor O'Rourke argues that this pressure has … Professor O'Rourke argues
that to ensure that patent law achieves … Professor O'Rourke proposes just such a defense …

Why do first-generation students fail?

SS Mehta, JJ Newbold, MA O'Rourke - College Student Journal, 2011 - go.gale.com
Previous studies have determined factors contributing to first-generation student success.
This study finds that first-generation students are less involved, have less social and financial …

DREAMseq (doublet, randomized evaluation in advanced melanoma sequencing): a phase III trial—ECOG-ACRIN EA6134.

…, AA Tarhini, TG Truong, D Davar, MA O'Rourke… - 2021 - ascopubs.org
356154 Background: Combinations of immune checkpoint inhibitors (CPI) blocking PD-1 and
CTLA-4 or BRAF/MEK inhibitors have both shown significant antitumor efficacy and overall …

[HTML][HTML] Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non–small-cell lung …

…, JR Caton, LC DeMarco, MA O'Rourke… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
Purpose We evaluated the efficacy of gemcitabine versus gemcitabine and carboplatin in
patients with advanced non–small-cell lung cancer (NSCLC) and a performance status (PS) of …

Recommendations for obesity clinical trials in cancer survivors: American Society of Clinical Oncology statement

…, LM Minasian, MA O'Rourke… - Journal of Clinical …, 2015 - escholarship.org
… are associated with poor outcomes in other common malignancies, including prostate,4…
Cao Y, Ma J: Body mass index, prostate cancer-specific mortality, and biochemical recurrence: A …

[BOOK][B] Copyright in a global information economy

JE Cohen, LP Loren, RL Okediji, MA O'Rourke - 2019 - books.google.com
ORourke, Associate Provost for Faculty Affairs, Dean Emerita & Professor of Law, Boston …
library assistance of Steve Donweber, Terri Gallego ORourke, Mary Rumsey, and David Zopfi-…

Use of total neoadjuvant therapy for locally advanced rectal cancer: initial results from the pembrolizumab arm of a phase 2 randomized clinical trial

…, LA Kachnic, N Vijayvergia, MA O'Rourke… - JAMA …, 2021 - jamanetwork.com
Importance Total neoadjuvant therapy (TNT) is often used to downstage locally advanced
rectal cancer (LARC) and decrease locoregional relapse; however, more than one-third of …

Drawing the Boundary Between Copyright and Contract: Copyright Preemption of Software License Terms

MA O'Rourke - Duke LJ, 1995 - HeinOnline
The Copyright Act of 19761 (the" Act") sought to clarify the boundary between federal and state
enforcement of proprietary rights in works of authorship by specifically addressing federal …